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Introduction 
Maximum levels of dioxins in food and feed are set in the European legislation1,2 for 17 congeners of PCDD/Fs and 
levels for 12 congeners of DL-PCBs will be added soon3. The reference gas chromatography-high resolution mass 
spectrometry (GC-HRMS) method allows the individual identification and quantification of these 29 congeners at the 
ultra-trace level. Congener-specific data can be used as such for source tracking or be converted in toxic equivalents 
quantities (TEQs) based on the use of toxic equivalent factors6 (TEFs). Because the monitoring of dioxins in the food 
chain is very expensive using HRMS, sample screening methods are needed. The CALUX cell based assay has 
widely been proposed to screen dioxins in food and feed samples4,5. Compared to GC-HRMS, the CALUX AhR-
activation mediated response directly yield to a TEQ estimation based on a correlation with 2,3,7,8-TCDD induction 
of the assay. 
Comparison between GC-HRMS and CALUX results often shows discrepancies, due to differences between the 
WHO-TEF6 values and the CALUX REP7 (relative equivalent potency) assigned to each congener of dioxins, furans 
and DL-PCBs for a specific assay. Such differences make difficult the decision of compliance or suspicion of non 
compliance of samples submitted to biological screening. 
We present a retrospective evaluation of the dioxin response (DR)-CALUX screening by comparing DR-CALUX 
results to GC-HRMS results for 51 samples analyzed in parallel. 
Material 
Samples: DIFF-01(fish), DIFF-02 (pork), DIFF-03 (milk), DIFF-04 (fish oil), DIFF-05 (feed), as well as matrix-
specific reference samples (for milk, pork and fish) are samples issued from the DIFFERENCE European project. 
Other samples are the reference material BCR-533 (PCDD/F-spiked low level milk powder), internal quality control 
(QC) or unknown samples issued from the routine activity of the laboratory of mass spectrometry. QC samples and 
method blanks (BCs) were regularly run for QA/QC purposes. 
Extraction: For HRMS analyses of PCDD/Fs and dioxin-like PCBs, samples were extracted using pressurized 
liquid extraction (PLE) (Dionex ASE 200) and cleaned-up using the automated Power-PrepTM system (Fluid 
Management Systems Inc.)8. For DR-CALUX analyses, samples were liquid-liquid (LLE) extracted and cleaned-up 
according to the method proposed by BioDetection System (BDS)9. 
Analysis : HRMS. PCDD/Fs and non-ortho-PCBs were measured on an AutospecUltima (Micromass) coupled to 
an Agilent 6890 Series GC. The column was a 50 m VF-5MS (0.20 mm ID x 0.33 µm df) (Varian). Mono-ortho-PCBs 
and indicator PCBs were measured on an MAT95XL (ThermofinniganMAT) coupled to an Agilent 6890 Series GC. 
The column was a 25 m HT-8 (0.22 mm ID x 0.25 µm df) (SGE)8. DR-CALUX. It originated from BioDetection 
System (BDS, NL). Analyses were performed by exposing the cells (triplicates, 96-well plates) during 24h to sample 
extracts and to 2,3,7,8-TCDD standard solutions in DMSO diluted in culture medium. See previous report for 
details7. 
Results 
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Correction of CALUX results with a reference sample 
During the DIFFERENCE project, we evaluated the use of matrix-specific reference samples for raw DR-CALUX 
data correction. Each reference sample (milk, pork and fish) followed the entire matrix-specific sample preparation 
procedure. The ratio of the total TEQ (sum of PCDD/Fs and dioxin-like PCBs) concentration measured by GC-
HRMS over the DR-CALUX result for the reference samples were used as correction factors applied to raw DR-
CALUX data obtained for DIFF-01(fish), DIFF-02 (pork) and DIFF-03 (milk) samples. Both pork and fish reference 
samples had a congener profile that corresponded to a classical background contamination (similar to the pattern of 
the unknown samples) and good correlations between DR-CALUX-reference sample corrected values and GC-
HRMS data were observed (Figure 1). The situation was not as good for milk because the pattern observed in the 
reference sample (PeCB-118 was unusually high) was different from a classical background congener distribution 
for milk and this influenced the raw data correction, as if a non-matrix specific reference sample had been used. The 
direct consequence led to an unexpected low recovery for the milk sample, inducing an over-estimation of the 
reference sample corrected CALUX data. This correction was compared to a correction using an internal QC of 
spiked beef fat (1.7 pg PCDD/F WHO-TEQ/ g fat and 1.4 DL-PCB WHO-TEQ/g fat). For pork and fish samples, 
Figure 1 shows that both the reference sample and the internal QC correction are efficient to improve the correlation 
with the HRMS results. In the case of milk, because of the reasons described above, only the correction with the 
internal QC improves this correlation. 
  
Figure 1 Raw and corrected responses of the DR-CALUX assay versus GC-HRMS for the investigated samples 
(DIFF-01(fish), DIFF-02 (pork), DIFF-03 (milk)). 
DR-CALUX analysis of 51 food or feed samples 
DR-CALUX and GC-HRMS results issued from the analysis of 51 food and feed samples are displayed in Table I, 
and illustrated in Figure 2 in more details for milk samples. 
Apart from feed unknown samples, reference samples (REF sample), BCR-533 and internal quality controls (IQC), 
DR-CALUX results have been corrected using either a matrix specific reference sample or an internal QC sample 
(raw milk for unknown milk samples or spiked beef fat for the other samples). For GC-HRMS, the compliance is 
reported when “the analytical result exceeds the maximum level (of PCDD/F) beyond reasonable doubt, taking into 
account the measurement uncertainty”10. In practice, the measured value minus the estimated uncertainty (including 
additional parameters than just the RSDs issued from multiple measurements) must be above the regulation level for 
the sample to be declared non-compliant11. For the DR-CALUX screening approach, high rates of false compliance 
(false negative) are avoided by deciding of “non compliance” (sample “to be confirmed”) when the measured value 
plus the estimated uncertainty (for samples in figure 2, the CV of at least a duplicate determination) is above the 
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PCDD/F action level (Figure 2). 
Regulatory maximum1,2 and action12 levels for PCDD/Fs as well as for the sum of PCDD/Fs and dioxin-like (DL)-
PCBs (Total) are indicated in Table II. The value for ‘Total action level’ is set at 60% of the corresponding maximum 
level.  
 
Table II : PCDD/F 1,2 and preliminary total (PCDD/F + DL-PCB)3 maximum levels. PCDD/F12 and proposed total 
action levels (60% of the total maximum level) for feed and food samples. 
Comparisons to these regulatory levels are made in Table I. The evaluation of the DR-CALUX screening efficiency 
was set as “true”: 
1) when samples declared “compliant” (indicated as “-“) after screening were confirmed compliant by GC-HRMS, or, 
2) when samples declared “to be confirmed” (suspicious) (indicated as “+”) after screening were confirmed non-
compliant, or, 
3) when samples declared “to be confirmed” (suspicious) after screening were found to be compliant but > total 
(PCDD/F + PCB) maximum level by GC-HRMS, or, 
4) when samples declared “to be confirmed” (suspicious) after screening were found to be compliant but > PCDD/F 
or total action level by GC-HRMS. 
From Table I, the DR-CALUX screening efficiency was as following : 
% of false compliant samples : 2% 
% of false non compliant samples : 20% 
% of true decision (compliant or non compliant) : 78% 
Conclusions 
Our evaluation of the use of the DR-CALUX for screening of food and feed samples show a very low rate of false 
negative (2% of false compliant, i.e. one sample out of 51 exceeded the total action level), as well as an acceptable 
rate of false non compliant of 20 %. However, results from GC-HRMS show that those 20% of false non compliant 
samples contain significant amounts of PCDD/F or DL-PCBs, and thus deserve consideration as indicator of 
background contamination of food and feed samples as recommended by the EC 13,14. 
The DR-CALUX can be considered as a valuable low cost screening tool for the implementation of the PCDD/F level 
monitoring in food and feed. The upcoming extension of the European regulations to DL-PCBs will additionally re-
enforce this position. 
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Figure 2 : Comparison of DR-CALUX and GC-HRMS analysis of milk samples. DR-CALUX : mean ± standard 
deviation (at least duplicate determination). GC-HRMS : the uncertainty has been estimated to 22%. 
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Table I : DR-CALUX and GC-HRMS results of the analysis of 51 food or feed samples. For compliance decision 
(see text), the GC-HRMS uncertainty has been estimated to 22% and the DR-CALUX uncertainty was estimated to 
30%. 
DR-CALUX : - : compliant (< PCDD/F action level) ; + : suspicious (> PCDD/F action level).  
HRMS : - : compliant (< PCDD/F or PCDD/F + PCB maximum level); + : non compliant (> PCDD/F or PCDD/F + 
PCB maximum level); -* : compliant but > PCDD/F action level; -** : compliant but > total (PCDD/F + PCB) action 
level. 
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